Most Recent
Nike loses challenge to swoosh-like trade mark of Canberra football club
Intellectual Property 2025-10-22 11:34 pm By Sam Matthews

Nike has lost its challenge to a Canberra AFL club’s trade mark, with IP Australia finding that the “arc-like feature” depicting a football in flight was not deceptively similar to the sportswear giant’s iconic swoosh mark.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

High Court called on to overturn Aristocrat’s gaming patent win
Intellectual Property 2025-10-15 11:03 pm By Christine Caulfield

The High Court has been asked to clarify the extent to which computer-implemented ideas are eligible for patent protection, with IP Australia appealing a win for gaming giant Aristocrat.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Claws out as Puma appeals Tiger Woods’ brand trade mark
Intellectual Property 2025-10-13 10:10 am By Christine Caulfield

Puma has appealed its failed opposition to a trade mark for Tiger Woods’ golf apparel and equipment brand Sun Day Red, which the German sneaker giant argued was too similar to its iconic leaping cat mark.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Fashion label Portia & Scarlett wants access to founder’s devices
Intellectual Property 2025-10-13 11:37 pm By Christine Caulfield

Formalwear brand Portia & Scarlett, which has accused one of its founders of accessing confidential dress designs contained in two computer files, has asked a court for access to her personal devices.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Scidera’s bovine gene patent suit survives summary dismissal bid
Intellectual Property 2025-10-10 11:55 pm By Cat Fredenburgh

Animal drug company Zoetis has lost its bid for summary dismissal of claims that it infringed US-based animal genomics company Scidera’s bovine gene patent, with a judge saying its novel arguments were not so clear-cut and needed to be worked out at trial.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Pentana can’t withdraw admissions in misuse of market power case
Competition & Consumer Protection 2025-10-09 11:44 pm By Cindy Cameronne

A judge has declined car dealer software supplier Pentana’s bid to withdraw admissions made over four years ago in a dispute with competitor Titan DMS.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Samsung Bioepis shoots down Janssen patent for ulcerative colitis biologic
Intellectual Property 2025-10-09 11:59 pm By Cat Fredenburgh

Samsung Bioepis has successfully opposed Janssen’s bid to patent a monoclonal antibody to treat ulcerative colitis, but an IP Australia delegate has given the J&J-owned company a chance to fix its application.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Abbey appeals failure in bid to invalidate patent for antiparasitic drug
Intellectual Property 2025-10-08 11:39 pm By Cat Fredenburgh

Abbey Animal Health has appealed its loss in a suit seeking to invalidate rival Virbac’s patent for an antiparasitic drug.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

‘Argumentative and amorphous’: Startup attacks Fortescue’s call for seized docs in trade secrets row
Intellectual Property 2025-10-07 11:46 pm By Christine Caulfield

Green iron startup Element Zero is challenging a bid by Fortescue for access to nine million seized documents in their trade secrets spat, saying its rival has not met the test for proving inadequate discovery of material.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Abbey in ‘pyrrhic victory’ against Virbac over antiparasitic drug patent
Intellectual Property 2025-09-25 2:17 pm By Sam Matthews

Abbey Animal Health has managed only a “pyrrhic victory” in a patent case against rival Virbac over an antiparasitic drug, and must withdraw its Levamox Duo product from the market, a court has found.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?